1. Home
  2. SYRE vs LASR Comparison

SYRE vs LASR Comparison

Compare SYRE & LASR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SYRE
  • LASR
  • Stock Information
  • Founded
  • SYRE 2013
  • LASR 2000
  • Country
  • SYRE United States
  • LASR United States
  • Employees
  • SYRE N/A
  • LASR N/A
  • Industry
  • SYRE Biotechnology: Pharmaceutical Preparations
  • LASR Semiconductors
  • Sector
  • SYRE Health Care
  • LASR Technology
  • Exchange
  • SYRE Nasdaq
  • LASR Nasdaq
  • Market Cap
  • SYRE 1.1B
  • LASR 903.8M
  • IPO Year
  • SYRE 2016
  • LASR 2018
  • Fundamental
  • Price
  • SYRE $16.23
  • LASR $29.73
  • Analyst Decision
  • SYRE Strong Buy
  • LASR Strong Buy
  • Analyst Count
  • SYRE 6
  • LASR 6
  • Target Price
  • SYRE $57.60
  • LASR $27.42
  • AVG Volume (30 Days)
  • SYRE 681.2K
  • LASR 830.1K
  • Earning Date
  • SYRE 11-06-2025
  • LASR 11-06-2025
  • Dividend Yield
  • SYRE N/A
  • LASR N/A
  • EPS Growth
  • SYRE N/A
  • LASR N/A
  • EPS
  • SYRE N/A
  • LASR N/A
  • Revenue
  • SYRE N/A
  • LASR $216,913,000.00
  • Revenue This Year
  • SYRE N/A
  • LASR $23.44
  • Revenue Next Year
  • SYRE N/A
  • LASR $8.73
  • P/E Ratio
  • SYRE N/A
  • LASR N/A
  • Revenue Growth
  • SYRE N/A
  • LASR 9.79
  • 52 Week Low
  • SYRE $10.91
  • LASR $6.20
  • 52 Week High
  • SYRE $40.26
  • LASR $32.27
  • Technical
  • Relative Strength Index (RSI)
  • SYRE 52.04
  • LASR 53.36
  • Support Level
  • SYRE $15.87
  • LASR $28.41
  • Resistance Level
  • SYRE $17.18
  • LASR $32.27
  • Average True Range (ATR)
  • SYRE 0.88
  • LASR 1.46
  • MACD
  • SYRE 0.08
  • LASR -0.21
  • Stochastic Oscillator
  • SYRE 70.65
  • LASR 39.82

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

About LASR nLIGHT Inc.

nLight Inc is a United States-based company provider of power semiconductor and fiber lasers for aerospace and defense, industrial, and microfabrication applications. It designs, manufactures, and sells a range of power semiconductor lasers and fiber lasers that are typically integrated into laser systems. It operates in two segments: Laser Products, which includes semiconductor lasers, fiber lasers, and directed energy products; and Development segment includes revenue earned from research and development contracts. The majority of its revenue is generated from the Laser segment. The company's geographical segments include North America, Asia Pacific, and EMEA.

Share on Social Networks: